Data / Drug companies / Tayca Corporation
Tayca Corporation: 22 products in the FDA NDC directory, labeler code 61503
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Tayca Corporation (labeler code 61503) lists 22 products in the FDA National Drug Code Directory. By type: 17 bulk ingredients, 5 drugs for further processing. Its main marketing category is bulk ingredients. The newest product started marketing on January 1, 2026.
The request: Watch Tayca Corporation (FDA labeler code 61503): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 61503
- Products in commercial distribution
- 22
- Packages
- 28
- Finished drugs by generic name
- 0
- Prescription products
- 0
- Over the counter products
- 0
- Started marketing in the last 12 months
- 1
- Earliest marketing start
- September 10, 1993
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Bulk ingredients | 17 | 77.3% |
| Drugs for further processing | 5 | 22.7% |
Products by type
| Type | Products | Share |
|---|---|---|
| Bulk ingredients | 17 | 77.3% |
| Drugs for further processing | 5 | 22.7% |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Powder | 22 | 100% |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Zinc oxide | 61503-323 | Powder | Drugs for further processing | January 1, 2026 |
| Titanium dioxide | 61503-119 | Powder | Drugs for further processing | June 30, 2023 |
| Titanium dioxide | 61503-124 | Powder | Drugs for further processing | January 5, 2021 |
| Zinc oxide | 61503-322 | Powder | Drugs for further processing | November 1, 2020 |
| Titanium dioxide | 61503-125 | Powder | Drugs for further processing | November 1, 2020 |
| Titanium dioxide | 61503-121 | Powder | Bulk ingredients | January 1, 2016 |
| Zinc oxide | 61503-317 | Powder | Bulk ingredients | June 30, 2015 |
| Titanium dioxide | 61503-118 | Powder | Bulk ingredients | September 27, 2013 |
| Zinc oxide | 61503-313 | Powder | Bulk ingredients | March 27, 2012 |
| Titanium dioxide | 61503-115 | Powder | Bulk ingredients | January 30, 2012 |
| Titanium dioxide | 61503-113 | Powder | Bulk ingredients | September 16, 2010 |
| Titanium dioxide | 61503-315 | Powder | Bulk ingredients | November 18, 2009 |
| Zinc oxide | 61503-306 | Powder | Bulk ingredients | February 27, 2004 |
| Titanium dioxide | 61503-110 | Powder | Bulk ingredients | May 31, 2002 |
| Titanium dioxide | 61503-316 | Powder | Bulk ingredients | September 5, 2001 |
| Zinc oxide | 61503-204 | Powder | Bulk ingredients | December 29, 2000 |
| Zinc oxide | 61503-203 | Powder | Bulk ingredients | December 29, 2000 |
| Titanium dioxide | 61503-116 | Powder | Bulk ingredients | February 9, 1999 |
| Titanium dioxide | 61503-106 | Powder | Bulk ingredients | June 12, 1998 |
| Titanium dioxide | 61503-105 | Powder | Bulk ingredients | October 22, 1997 |
| Titanium dioxide | 61503-301 | Powder | Bulk ingredients | November 28, 1996 |
| Titanium dioxide | 61503-104 | Powder | Bulk ingredients | September 10, 1993 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.